Key result
Cerebrovascular multimorbidity pattern in young STEMI women linked to ~129% higher in-hospital adverse event risk.
Why the study?
Do specific multimorbidity patterns increase the risk of in-hospital adverse events in young women presenting with ST-segment-elevation myocardial infarction?
Cohort (n=9,570)
Yes
Do specific multimorbidity patterns increase the risk of in-hospital adverse events in young women presenting with ST-segment-elevation myocardial infarction?
Specific multimorbidity patterns, such as cerebrovascular and anemia-renal dysfunction clusters, are associated with significantly higher risks of in-hospital adverse events in young women with STEMI.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for multimorbidity-based risk stratification in young women with STEMI; prospective trials needed before clinical adoption.
Background: Recent evidence highlights an increasing incidence of myocardial infarction in young women. Identifying clinical multimorbidity patterns in this population may improve therapeutic strategies and clinical care. Methods and Results: We identified multimorbidity patterns in 9570 young women with ST‐segment–elevation myocardial infarction (median age, 50 years [range, 47.0–53.0 years]) admitted to the China Chest Pain Center Database between 2016 and 2021. Hierarchical clustering of 15 medical conditions was performed to derive multimorbidity patterns. The primary outcome was a composite of in‐hospital adverse events. Associations between multimorbidity patterns and outcomes were evaluated using multivariable‐adjusted logistic regression models. Among 9570 patients, 50% (n=4789) had multimorbidity. Six multimorbidity patterns were identified, including 4 specific patterns: (1) pattern 1, cerebrovascular cluster (histories of cerebrovascular disease and hypertension); (2) pattern 2, traditional cardiovascular disease risk factors cluster (histories of hyperlipidemia, obesity, and diabetes, and family history of cardiovascular disease and smoking); (3) pattern 3, coronary‐heart failure cluster (histories of heart failure, coronary artery disease, peripheral arterial disease, and thyroid dysfunction); and (4) pattern 4, anemia‐renal dysfunction cluster (histories of atrial fibrillation, anemia, chronic kidney disease, and peptic ulcer). Compared with patients without multimorbidity, those with pattern 1 (odds ratio [OR], 2.29 [95% CI, 1.49–3.52]), pattern 2 (OR, 1.52 [95% CI, 1.24–1.86]), and pattern 4 (OR, 2.25 [95% CI, 1.10–4.61]) exhibited higher risks for composite outcomes. Conclusions: Specific multimorbidity patterns in young women with ST‐segment–elevation myocardial infarction were associated with distinct in‐hospital outcomes in a nationwide registry, providing proof‐of‐concept evidence to guide future therapeutic approaches.
No takes yet. Share an insight, caveat, or question.
Geru et al. (2025) conducted a cohort in ST-segment-elevation myocardial infarction (n=9,570). Multimorbidity patterns (e.g., cerebrovascular cluster) vs. Patients without multimorbidity was evaluated on Composite of in-hospital adverse events (OR 2.29, 95% CI 1.49-3.52). The cerebrovascular multimorbidity pattern in young women with STEMI was associated with a higher risk of in-hospital adverse events compared to no multimorbidity.
Synapse has enriched 10 related papers. Consider them for comparative context: